Horne, R., Grant, T
A Clinical Review At a glance Drug reviewed / Adderall XR (mixed amphetamine salts, extended-release) Supplement / Zinc (elemental forms: gluconate, sulfate, picolinate, citrate) Interaction category / Pharmacodynamic (CNS) plus micronutrient competition Clinical severity / Low to moderate
Tarantini, G., Scrutinio, D., Bruzzi, P., Boni, L., Rizzon, P., and Iliceto, S
Tirzepatide (Mounjaro, Zepbound) produces around 20.9% body weight loss at 72 weeks in the SURMOUNT-1 trial
12.3 Pharmacokinetics Semaglutide estimated mean steady-state concentration was 6.7 nmol/L and 14.6 nmol/L following once daily oral administration of 7 mg and 14 mg of RYBELSUS, respectively, in patients with type 2 diabetes mellitus